BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12132442)

  • 1. Side effects. Severe nevirapine rash found more likely in women than men.
    TreatmentUpdate; 2001; 12(8):7. PubMed ID: 12132442
    [No Abstract]   [Full Text] [Related]  

  • 2. Gender difference in Nevirapine-associated rash.
    Proj Inf Perspect; 1999 Apr; (27):11. PubMed ID: 11366728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization to Nevirapine.
    TreatmentUpdate; 1999 Nov; 11(8):5. PubMed ID: 11367044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
    Santos RP; Ramilo O; Barton T
    Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-Cw8 primarily associated with hypersensitivity to nevirapine.
    Gatanaga H; Yazaki H; Tanuma J; Honda M; Genka I; Teruya K; Tachikawa N; Kikuchi Y; Oka S
    AIDS; 2007 Jan; 21(2):264-5. PubMed ID: 17197830
    [No Abstract]   [Full Text] [Related]  

  • 6. Nevirapine precautions published.
    AIDS Treat News; 2004 Feb; (398):5. PubMed ID: 15119290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
    Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevirapine hypersensitivity.
    Popovic M; Shenton JM; Chen J; Baban A; Tharmanathan T; Mannargudi B; Abdulla D; Uetrecht JP
    Handb Exp Pharmacol; 2010; (196):437-51. PubMed ID: 20020271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients.
    Littera R; Carcassi C; Masala A; Piano P; Serra P; Ortu F; Corso N; Casula B; La Nasa G; Contu L; Manconi PE
    AIDS; 2006 Aug; 20(12):1621-6. PubMed ID: 16868443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New nevirapine label underscores the risk for hepatotoxicity in key populations.
    AIDS Clin Care; 2004 Mar; 16(3):24. PubMed ID: 15119295
    [No Abstract]   [Full Text] [Related]  

  • 11. Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity.
    Raffi F; Lewden C; Chêne G
    AIDS; 2008 Jan; 22(3):435-6. PubMed ID: 18195573
    [No Abstract]   [Full Text] [Related]  

  • 12. Appropriate use of nevirapine for long-term therapy.
    Leith J; Piliero P; Storfer S; Mayers D; Hinzmann R
    J Infect Dis; 2005 Aug; 192(3):545-6; author reply 546. PubMed ID: 15995971
    [No Abstract]   [Full Text] [Related]  

  • 13. Nevirapine levels may predict toxicity.
    TreatmentUpdate; 2002 Feb; 14(2):6-7. PubMed ID: 12691043
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.
    Sanne I; Mommeja-Marin H; Hinkle J; Bartlett JA; Lederman MM; Maartens G; Wakeford C; Shaw A; Quinn J; Gish RG; Rousseau F
    J Infect Dis; 2005 Mar; 191(6):825-9. PubMed ID: 15717255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virammune and women in the news.
    Emery C
    Surviv News (Atlanta Ga); 2005; 16(2):10. PubMed ID: 16158512
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffuse interstitial pulmonary opacities induced by nevirapine.
    Sankatsing SU; Schouten WE
    AIDS; 2007 Sep; 21(14):1993-4. PubMed ID: 17721119
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex differences in nevirapine rash.
    Bersoff-Matcha SJ; Miller WC; Aberg JA; van Der Horst C; Hamrick HJ; Powderly WG; Mundy LM
    Clin Infect Dis; 2001 Jan; 32(1):124-9. PubMed ID: 11118391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread vitiligo after erythroderma caused by nevirapine in a patient with AIDS.
    Ramírez-Hernández M; Sánchez-Sierra B; Martínez-Escribano JA
    Acta Derm Venereol; 2007; 87(5):442-3. PubMed ID: 17721659
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV
    Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
    [No Abstract]   [Full Text] [Related]  

  • 20. Third-trimester maternal toxicity with nevirapine use in pregnancy.
    Joy S; Poi M; Hughes L; Brady MT; Koletar SL; Para MF; Fan-Havard P
    Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1032-8. PubMed ID: 16260522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.